Request Info

Nico.lab B.V.

  • Nico.lab’s StrokeViewer® uses AI to reduces time-to-decision for stroke patients to 3 minutes compared to the current manual protocol which can take hours.

  • StrokeViewer® has been approved for roll-out by 15 hospitals.

  • The company has an exceptional management team and board, with over €4M and years of research spent to date.

  • Investors have an opportunity at a compelling €4.5M pre-money valuation, ahead of an ASX listing in 1Q18.